Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Increlex

PharmaCompass

01

Brand Name : Increlex

Mecasermin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Increlex

arrow
2024 ACI Convention
Not Confirmed

Mecasermin

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2015 Revenue in Millions : 14

2014 Revenue in Millions : 22

Growth (%) : 57%

blank

02

Brand Name : Increlex

Mecasermin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Increlex

arrow
2024 ACI Convention
Not Confirmed

Mecasermin

Main Therapeutic Indication : Metabolic Disorders

Currency : USD

2016 Revenue in Millions : 25

2015 Revenue in Millions : 21

Growth (%) : 20

blank

03

Brand Name : Increlex

Mecasermin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Increlex

arrow
2024 ACI Convention
Not Confirmed

Mecasermin

Main Therapeutic Indication : Metabolic Disorders

Currency : USD

2017 Revenue in Millions : 28

2016 Revenue in Millions : 29

Growth (%) : -3

blank

04

Brand Name : Increlex

Mecasermin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Increlex

arrow
2024 ACI Convention
Not Confirmed

Mecasermin

Main Therapeutic Indication : Metabolic Disorders

Currency : USD

2018 Revenue in Millions : 27

2017 Revenue in Millions : 26

Growth (%) : 5%

blank

05

Brand Name : Increlex

Mecasermin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Increlex

arrow
2024 ACI Convention
Not Confirmed

Mecasermin

Main Therapeutic Indication : Hormonal Disorders

Currency : USD

2014 Revenue in Millions : 1%

2013 Revenue in Millions :

Growth (%) :

blank